Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 829 of 1,261
  1. US 8658691

    Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound

    Theravance, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  2. US 8658694

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  3. US 8652458

    Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  4. US 8653137

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  5. US 8653103

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  6. US 8653283

    Anticancer agents

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  7. US 8653243

    Pertussis antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  8. US 8653286

    Intermediates useful in the preparation of maleimide functionalized polymers

    Nektar Therapeutics · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  9. US 8653107

    Fentanyl composition for nasal administration

    Takeda Pharma A/S · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  10. US 8653088

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  11. US 8653094

    Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  12. US 8653061

    Acetylcysteine composition and uses thereof

    Cumberland Pharmaceuticals Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  13. US 8653060

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  14. US 8653055

    Corticosteroid having low systemic absorption

    Teva Animal Health, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  15. US 8653034

    Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

    The Board of Regents of the University of Texas System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  16. US 8653057

    Prophylactic perioperative testosterone supplementation for protection of and recovery of function

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  17. US 8653033

    Method for administering omega-conopeptide

    Jazz Pharmaceuticals International III Limited · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  18. US 8652836

    Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response

    Providence Health System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  19. US 8652787

    Use of ERBB4 as a prognostic and therapeutic marker for melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  20. US 8652492

    Wet granulation using a water sequestering agent

    Rigel Pharmaceuticals, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  21. US 8652512

    Nebulized liposomes for the pulmonary application of drug compounds

    United Therapeutics Corporation · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  22. US 8652516

    Doxycycline formulations, and methods of treating rosacea

    Cerovene, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  23. US 8652503

    Bone paste

    Regeneration Technologies, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  24. US 8652475

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.